Among the coccus family, Streptococcus is a gram-positive bacterium. It belongs to the phylum Bacillota and the order Lactobacillales. The cell division of a streptococcus is on a single axis. Often, the bacteria form chains or pairs of cells.
Among the many human pathogenic bacteria, Streptococcus Group A (GAS) is one of the most common causes of infection and disease. It is known to cause a range of infections, from mild skin and wound infections to life-threatening necrotizing fasciitis. A Group A Strep infection can be prevented by following a few simple precautions.
The most important risk factor for developing Group A Streptococcus is having a skin wound or cut. If you have a cut or skin wound, you should watch it closely for signs of infection. If you do notice an infection, see a healthcare professional immediately.
The most common types of Group A Strep infections are throat infections and skin infections. These can be treated with antibiotics. If the infection is severe, a surgical procedure may be required to remove the tissue affected by the disease. It is recommended that you discuss the benefit of using preventive antibiotics with your healthcare provider.
A Group A Streptococcus infection can be prevented if you wash your hands regularly. Avoiding close contact with people who have a symptom of a strep infection is also highly recommended.
There is a growing concern about an increase in invasive Group A Streptococcus disease in children in the United States. Those with a symptom should be tested for an infection, but not all household contacts should be tested. Infections can occur in the lungs, spleen, liver, kidneys, and skin.
Group A Streptococcus is a common cause of tonsillopharyngitis, a bacterial throat infection. Acute rheumatic fever, myositis, and septic arthritis are other potential complications of this disease.
The risk of developing an invasive Group A Streptococcus infection is a minor risk in the general population. However, individuals with underlying diseases or conditions are at higher risk of developing an invasive Group A Streptococcus infection. Those who have a history of rheumatic heart disease or other conditions are at a greater risk of developing an invasive Group A Streptococcus.
Group A Streptococcus has been a major cause of death in industrialized countries for hundreds of years, before antibiotics. In the 1980s, there was a resurgence in serious Group A Streptococcus disease, especially in the Rocky Mountain states of the USA.
Among the most important and well-studied bacteria are Group A streptococci. They are the cause of a number of infections in humans, including septic arthritis, osteomyelitis, impetigo, and pneumonia. The cells of these bacteria contain a polysaccharide composed of acetylglucosamine and rhamnose. These compounds are produced by the bacteria for adherence and immunological disguise.
They produce a wide range of virulence factors, including exotoxins, streptolysins, hyaluronidase, and M proteins. These virulence factors contribute to the pathogenesis of GAS. The production of exopolysaccharides is associated with the ability to adhere to cardiac valves and to form vegetation on the valve leaflets. It is also associated with the reduction of red cell hemoglobin.
Various virulence factors have been identified, and are used in clinical diagnosis. However, antibodies to these soluble extracellular growth products are not very protective. They are leukotoxic, and they can increase after skin and pharyngeal infection. The presence of these antigens may explain autoimmune responses to these infections.
The hemolytic reaction of Streptococcus pneumoniae has been described as rapid partial autolysis that occurs during anaerobic incubation. The presence of a characteristic halo on the bacterial surface is also known. This reaction is caused by the presence of hydrogen peroxide and is associated with the reduction of red-cell hemoglobin. This halo is not present in genetically engineered mutants.
The pathogenic potential of non-group-A streptococci for humans has also been clarified. In some cases, the presence of these bacteria has been associated with neonatal septicemia, meningitis, and other types of infections. These organisms are less well-known for their virulence factors.
The antihyaluronidase titer peaks 6-8 weeks after the acute infection. The M protein is a virulence factor that is produced by streptococcus. This protein may serve as an epidemiologic marker.
The antihyaluronidase, the M protein, and other virulence factors are produced by the Streptococcus pyogenes bacterium. These factors are produced in pairs of cells. They are the source of a number of diseases, including pneumonia with empyema, necrotizing fasciitis, and otitis. The prevalence of a variety of S pyogenes infections has increased in the last several decades, and strain variants have been reported to differ from each other.
Resistance to antibiotics
Several studies have shown that antibiotic resistance in Streptococcus pneumoniae is increasing. The presence of multi-drug-resistant bacteria has increased in both hospitals and community settings. This poses a significant challenge for the treatment of community-acquired pneumonia. Moreover, inappropriate practices by prescribers and dispensers contribute to the high level of S. pneumoniae antibiotic resistance. Ultimately, understanding the susceptibility profile of pathogens and other mechanisms of failure can help to reduce ineffective antibiotic use.
Scientists in Vietnam conducted a study to determine the prevalence of antibiotic resistance in S. pneumoniae isolates from children in a defined community in Hanoi. They also compared the results with data from clinical isolates from 16 Vietnamese hospital laboratories. They found that 221 of the 546 isolates tested were resistant to at least one antibiotic.
The results showed that there was a high rate of resistance to common antibiotics such as erythromycin, benzyl-penicillin, trimethoprim-sulphamethoxazole, vancomycin, and moxifloxacin. This was compared to the results from a study carried out in 2007. In 2007, only one-third of the bacterial isolates tested were resistant to erythromycin, benzyl-penicillin, and trimethoprim-sulphamethoxazole. The study concluded that the antibiotic resistance rate in Streptococcus pneumoniae increased in 2007 and 2014. This is a significant public health concern.
The study included 546 preschool children in 460 households in the rural BaVi District of Hanoi. They were asked to consent to participate in the study. The researchers collected cultures from the children and their caregivers. The isolates were grown and cultured to determine the antimicrobial susceptibility of the strains. A multiplex polymerase chain reaction was used to identify the resistance determinants of the strains.
The study found that a mutation to the pbp2x gene in Streptococcus pyogenes reduced susceptibility to cefotaxime. This mutation had not been previously observed in b-hemolytic streptococci. However, mutation-harboring strains are not resistant and do not meet the definition of true resistance. They are not able to acquire new resistance determinants, but they are not unable to spread between patients.
The mutation-harboring strains are not susceptible to beta-lactam antibiotics, but they do not have a detrimental fitness effect. These strains do not prevent the organism from spreading, but they are not resistant to the laboratory definition of true resistance.
Signs and symptoms
Symptoms of Streptococcus can vary greatly from person to person, depending on the type of bacteria that is causing the infection. In some cases, the bacteria may only cause a mild illness. In others, the disease can become more severe. In both cases, the bacteria will affect the throat, skin, and muscles. The bacteria are often transmitted through sneezing, coughing, or sharing food or drinks with another person.
The signs and symptoms of Group A Streptococcus are similar to those of other illnesses and can include fever, sore throat, nausea, and vomiting. However, some patients can develop a serious complication called necrotizing fasciitis. This infection causes severe swelling of the skin and tissue, which can be painful.
Invasive Group A Streptococcus (GAS) disease can be life-threatening, especially if left untreated. It can invade the lungs, blood, and deep muscle tissues. The disease can cause a dangerous drop in blood pressure, as well as organ damage. These complications are more likely to occur in people with weak immune systems. The disease is often treated with antibiotics.
If you are diagnosed with Group A Streptococcus, you should follow the complete treatment plan prescribed by your health care provider. This will help reduce your symptoms and prevent complications. You should also drink lots of fluids to keep your body hydrated. You should also avoid eating solid foods, as the bacteria can grow in your gastrointestinal tract. If you have a sore throat, try to eat some cold liquids to relieve your discomfort.
Invasive GAS infections can also result in rheumatic fever, a complication that can lead to permanent damage to the heart valves. You may also have blood in your urine, and your kidneys may swell.
Invasive Group A Streptococcus infections are common in children but are rare in adults. If you are diagnosed with Group A Streptococcus, it is important to take antibiotics to stop the bacteria from growing in your body. This will also lower the risk of serious complications, such as rheumatic fever.
You should also be careful not to share anything with anyone who has strep throat. You can prevent the spread of the bacteria by covering your mouth when you talk or swallow.
Health A to Z. (n.d.). HSE.ie. https://www2.hse.ie/az/
U.S. National Library of Medicine. (n.d.). https://www.ncbi.nlm.nih.gov/
Directory Health Topics. (n.d.). https://www.healthline.com/directory/topics
Health A-Z. (2022, April 26). Verywell Health. https://www.verywellhealth.com/health-a-z-4014770
Harvard Health. (2015, November 17). Health A to Z. https://www.health.harvard.edu/health-a-to-z
Health Conditions A-Z Sitemap. (n.d.). EverydayHealth.com. https://www.everydayhealth.com/conditions/